5096 related articles for article (PubMed ID: 26003072)
1. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
2. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
3. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
[TBL] [Abstract][Full Text] [Related]
4. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity.
Chotirmall SH; Branagan P; Gunaratnam C; McElvaney NG
Respir Care; 2008 Aug; 53(8):1035-41. PubMed ID: 18655741
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
Jubin V; Ranque S; Stremler Le Bel N; Sarles J; Dubus JC
Pediatr Pulmonol; 2010 Aug; 45(8):764-71. PubMed ID: 20597074
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
Skov M; McKay K; Koch C; Cooper PJ
Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
[TBL] [Abstract][Full Text] [Related]
7. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.
Mastella G; Rainisio M; Harms HK; Hodson ME; Koch C; Navarro J; Strandvik B; McKenzie SG
Eur Respir J; 2000 Sep; 16(3):464-71. PubMed ID: 11028661
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
de Vrankrijker AM; van der Ent CK; van Berkhout FT; Stellato RK; Willems RJ; Bonten MJ; Wolfs TF
Clin Microbiol Infect; 2011 Sep; 17(9):1381-6. PubMed ID: 21087348
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.
Ritz N; Ammann RA; Casaulta Aebischer C; Schoeni-Affolter F; Schoeni MH
Eur J Pediatr; 2005 Sep; 164(9):577-82. PubMed ID: 15926067
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus bronchitis in cystic fibrosis.
Shoseyov D; Brownlee KG; Conway SP; Kerem E
Chest; 2006 Jul; 130(1):222-6. PubMed ID: 16840406
[TBL] [Abstract][Full Text] [Related]
12. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
13. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).
Kanu A; Patel K
Pediatr Pulmonol; 2008 Dec; 43(12):1249-51. PubMed ID: 19009619
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
De Baets F; De Keyzer L; Van Daele S; Schelstraete P; Van Biervliet S; Van Braeckel E; Thomas M; Wanyama SS
Pediatr Allergy Immunol; 2018 Nov; 29(7):726-731. PubMed ID: 29981532
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for allergic bronchopulmonary aspergillosis in Indian children with cystic fibrosis.
Sharma VK; Raj D; Xess I; Lodha R; Kabra SK
Indian Pediatr; 2014 Apr; 51(4):295-7. PubMed ID: 24825267
[TBL] [Abstract][Full Text] [Related]
16. Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.
Hassanzad M; Mortezaee V; Bongomin F; Poorabdollah M; Sharifynia S; Maleki M; Hedayati N; Velayati AA; Hedayati MT
J Mycol Med; 2019 Jun; 29(2):189-192. PubMed ID: 30782501
[TBL] [Abstract][Full Text] [Related]
17. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
Nepomuceno IB; Esrig S; Moss RB
Chest; 1999 Feb; 115(2):364-70. PubMed ID: 10027433
[TBL] [Abstract][Full Text] [Related]
18. Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis.
Emiralioğlu N; Doğru D; Doğan Ö; Gülmez D; Akdağlı SA; Polat SE; Tuğcu G; Hızal MG; Yalçın E; Özçelik U; Şener B; Kiper N
Turk J Pediatr; 2020; 62(4):560-568. PubMed ID: 32779408
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients.
Fillaux J; Brémont F; Murris M; Cassaing S; Rittié JL; Tétu L; Segonds C; Abbal M; Bieth E; Berry A; Pipy B; Magnaval JF
Scand J Infect Dis; 2012 Nov; 44(11):842-7. PubMed ID: 22831545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
